Fact-checked by Grok 2 weeks ago

Chemosis

Chemosis is a medical condition characterized by the or swelling of the , the thin, transparent that lines the inner surface of the eyelids and covers the anterior portion of the , often presenting as a blister-like or fluid-filled protrusion on the ocular surface. This swelling results from the accumulation of fluid in the conjunctival tissues, typically indicating underlying irritation or inflammation of the eye. Chemosis arises from a variety of etiologies, most commonly allergic reactions, which trigger an inflammatory response in the leading to and fluid leakage. Infectious causes, including bacterial or viral , can also induce chemosis through inflammatory mediators. Additionally, it may occur secondary to , such as blunt to the eye, or as a complication following ocular surgeries like , where disruption of lymphatic drainage contributes to persistent . Other factors include exposure to irritants, certain medications, or systemic conditions like , though these are less frequent. Clinically, chemosis manifests primarily as visible conjunctival swelling that can range from mild to severe, sometimes forming a tense, gelatinous elevation that separates the from the underlying . Accompanying symptoms often include ocular irritation, foreign body sensation, excessive tearing, , and in cases of significant swelling, difficulty closing the eyelids (), which may lead to corneal exposure and dryness. Unlike , chemosis is generally painless and non-tender, though associated redness or itching may occur depending on the cause. is primarily clinical, involving a detailed history to ascertain onset, exposures, and systemic symptoms, supplemented by slit-lamp biomicroscopy to assess the extent of swelling and rule out differentials like or thyroid eye disease. Management of chemosis is tailored to the underlying and severity. For allergic causes, topical antihistamines, mast cell stabilizers, or corticosteroids, along with cool compresses, effectively reduce and . Infectious chemosis requires targeted therapy, such as topical antibiotics for bacterial cases or supportive care for viral etiologies. In postoperative scenarios, conservative measures like preservative-free lubricants, hypertonic saline drops, and taping the eyelid at night are initial steps, with escalation to subconjunctival steroids or surgical techniques like conjunctival resection for cases. Early intervention is crucial to prevent complications such as secondary infection, , or chronic exposure keratopathy, and the prognosis is favorable with prompt treatment, often resolving within days to weeks.

Definition and Characteristics

Definition

Chemosis is defined as the swelling or of the , the thin, transparent membrane that lines the inner surface of the eyelids and covers the white part of the eye (), resulting from the accumulation of fluid in the conjunctival tissues. This condition manifests as a blister-like protrusion of the that extends beyond the , the border between the and , giving the eye a characteristic puffy or gelatinous appearance. The term "chemosis" originates from the Greek word "cheme," meaning cockleshell, alluding to the shelled or blistering resemblance of the swollen to a cockle shell. This etymological reference highlights the visible, outward-bulging feature that distinguishes the condition in clinical observation. Chemosis specifically involves the buildup of transudative or exudative fluid within the conjunctival layers due to increased , differing from related ocular conditions such as bulbar conjunctival injection, which refers to redness caused by dilation of conjunctival blood vessels without swelling, or subconjunctival hemorrhage, which entails the accumulation of blood beneath the conjunctiva resulting in a flat, bright red patch rather than edematous protrusion.

Clinical Features

Chemosis manifests as a prominent, blister-like swelling of the , the thin membrane covering the and inner eyelids, resulting from fluid accumulation that imparts a gelatinous or inflated appearance. This often localizes to the limbal region near the corneal border, creating a bulging effect, and it can affect one eye (unilateral) or both eyes (bilateral) depending on the extent of involvement. Clinicians chemosis based on the of conjunctival protrusion and involvement to assess severity and guide . Mild chemosis involves slight limbal with minimal fluid accumulation and limited protrusion. Moderate chemosis features extension of the swelling 3-5 mm beyond the limbus, with noticeable billowing and moderate conjunctival protrusion. Severe chemosis presents as full ballooning of the , marked exceeding 5 mm, and significant protrusion that may impair closure and raise the risk of corneal exposure. The condition typically causes due to irregularity of the ocular surface from the swollen , though it is generally painless without secondary or complications. This visual disturbance arises from the pathophysiological disrupting tear film stability, as detailed in the mechanisms of section.

Pathophysiology

Mechanisms of Edema

Chemosis arises primarily from increased vascular permeability in the conjunctival capillaries, which allows the transudation of plasma proteins and fluid into the interstitial spaces, resulting in localized swelling. This permeability is often triggered by histamine release from mast cells, particularly in allergic responses, leading to endothelial cell contraction and gaps in the vascular barrier. Cytokine mediation, such as through interleukin-6 (IL-6), further promotes endothelial dysfunction and leakage by activating signaling pathways that disrupt tight junctions. Endothelial damage from direct insult, such as in trauma or infection, also contributes by compromising the integrity of the capillary wall, facilitating fluid extravasation. The underlying this follow Starling's principle, where an imbalance between hydrostatic and s drives net fluid movement out of the capillaries into the tissue. Elevated hydrostatic pressure within conjunctival vessels, often due to inflammation-induced , pushes fluid outward, while reduced from protein leakage fails to draw it back. This process is exacerbated by impaired lymphatic drainage in the , which normally reabsorbs excess interstitial fluid; obstruction or overload from swelling creates a cycle of accumulation without deeper orbital extension. In the inflammatory , mast cell degranulation in allergic chemosis releases and other mediators that initiate acute permeability changes and recruit additional inflammatory cells. In infectious cases, bacterial endotoxins trigger a similar by stimulating production from resident immune cells, amplifying vascular leakage and while confining the response to the superficial . These mechanisms ensure the edema remains localized, distinguishing chemosis from more invasive orbital pathologies.

Anatomical Involvement

The is a thin, transparent that lines the inner surface of the eyelids (palpebral conjunctiva) and covers the anterior portion of the (bulbar conjunctiva), extending from the to the fornices. It consists of a non-keratinized , typically five to six cell layers thick, overlying a vascularized substantia propria (stroma) that includes fibroblasts, immune cells, and accessory lacrimal glands. Embedded within the are goblet cells, which secrete to contribute to the tear film's mucoid layer, ensuring ocular surface and stability. In chemosis, the condition primarily affects the bulbar , particularly the region adjacent to the limbus, where causes visible swelling and protrusion. Severe cases may extend to the fornices, leading to pooling of fluid in these recessed areas, but deeper structures such as are generally spared unless the is advanced and persistent. Normally, the serves as a protective barrier against microbial and environmental irritants while maintaining tear film integrity through production and smooth gliding of the s over the ocular surface. Chemosis disrupts these functions by mechanically interfering with and tear distribution, potentially leading to exposure and further surface instability. This anatomical involvement arises from localized , as explored in the mechanisms of section.

Etiology

Allergic and Inflammatory Causes

Chemosis frequently arises from allergic reactions mediated by , where exposure to environmental allergens triggers and subsequent in the . Common triggers include airborne allergens such as in seasonal () and perennial allergens like dust mites or animal dander in non-seasonal forms, leading to conjunctival edema as fluid leaks into the tissue. Contact lens wear can exacerbate this through mechanical irritation combined with to lens deposits or solutions, often manifesting as giant papillary with prominent chemosis. In atopic individuals, variants may contribute, where deeper tissue swelling extends to the periorbital region, amplifying conjunctival involvement. Inflammatory conditions represent another key non-infectious , often involving chronic immune activation. Vernal keratoconjunctivitis (VKC), a severe allergic disorder prevalent in young males with , features recurrent episodes of conjunctival with marked chemosis, hyperemia, and mucous discharge due to Th2-mediated responses. Atopic keratoconjunctivitis (AKC), associated with systemic , similarly presents with persistent bulbar conjunctival chemosis alongside frequent corneal involvement. Thyroid eye disease (TED), or , is an autoimmune inflammatory process linked to , where orbital fibroblasts produce excess glycosaminoglycans that retain water, causing periorbital and conjunctival including chemosis in moderate to severe cases. Superior limbic keratoconjunctivitis (SLK), a chronic inflammatory disorder of unclear but possibly linked to mechanical friction or , involves superior bulbar conjunctival redundancy and that can manifest as localized chemosis. These allergic and inflammatory triggers are prevalent in ocular presentations, particularly during peak seasonal exposure.

Infectious Causes

Infectious causes of chemosis primarily involve microbial pathogens that provoke conjunctival edema through direct invasion, inflammation, or toxin production. Bacterial infections, such as acute bacterial , are common culprits, often presenting with purulent discharge and conjunctival swelling. Common pathogens include and , which lead to hyperemia, chemosis, and mucopurulent , typically resolving with topical antibiotics but potentially progressing to more severe involvement if untreated. In severe cases, bacterial infections can extend to , where chemosis accompanies proptosis, ophthalmoplegia, and eyelid edema due to intraorbital pressure elevation from contiguous spread, often requiring systemic antibiotics and possible surgical intervention. Viral infections frequently induce chemosis via epithelial disruption and immune-mediated responses. Adenoviral keratoconjunctivitis, including epidemic keratoconjunctivitis, manifests with bilateral conjunctival injection, chemosis, watery discharge, and preauricular , affecting up to 90% of viral cases and spreading rapidly through contaminated surfaces. involvement typically presents as unilateral follicular with chemosis, vesicular lid lesions, and potential corneal dendrites, necessitating antiviral therapy to prevent progression. Other infections include chlamydial causes, such as -induced inclusion or , where chronic or recurrent exposure leads to follicular , hyperemia, and chemosis, particularly in endemic areas or sexually active adults. Fungal infections, though rarer, occur in immunocompromised patients and can cause chemosis through or orbital extension, often involving or species following or systemic , with outcomes dependent on early therapy. Since 2020, COVID-19-associated has shown increased incidence of chemosis, with symptoms like hyperemia and epiphora in up to 31% of cases, linked to direct ocular .

Traumatic and Other Causes

Traumatic causes of chemosis involve direct mechanical or chemical to the ocular surface, leading to conjunctival through disruption of vascular integrity and inflammatory mediator release, such as and . , for instance, can result in chemosis disproportionate to other signs, potentially indicating underlying scleral rupture, as seen in a case of a sustaining from sleep-walking into a dresser, where chemosis resolved over one month with supportive measures like . Chemical burns, particularly from alkalis responsible for approximately 60% of such injuries, cause immediate conjunctival swelling due to and osmotic effects, often requiring urgent irrigation and monitoring for deeper damage. irritation similarly provokes chemosis via localized and secondary , as documented in cases of mechanical insult leading to conjunctival without . Surgical represents a common iatrogenic , where manipulation of periocular tissues disrupts lymphatic drainage and increases , resulting in persistent chemosis. Following lower eyelid , chemosis occurs in approximately 26% of cases, with increased risk when intraoperative canthopexy is performed. In surgery, chemosis arises from conjunctival incision and traction, typically resolving spontaneously but occasionally requiring intervention if chronic. overwear can induce iatrogenic chemosis through corneal and epithelial compromise, often complicating bacterial with associated conjunctival in extended-wear users. Systemic conditions contribute to chemosis by promoting generalized fluid retention or venous congestion, exploiting the conjunctiva's anatomical vulnerability to . , caused by obstruction from or , leads to conjunctival chemosis through elevated venous and facial , manifesting as a key diagnostic sign alongside neck vein distension. In renal failure with fluid overload, such as , hypoproteinemia drives severe periorbital and conjunctival , with chemosis resolving upon and protein restoration. Exposure keratopathy in comatose or critically ill patients, particularly those on , is frequently associated with chemosis, which occurs in 26.9% of such patients.

Clinical Presentation

Signs and Symptoms

Patients with chemosis typically experience a range of ocular symptoms, including itching, excessive tearing, a sensation, and , which contribute to overall eye discomfort. Unlike conditions involving severe ocular , chemosis is generally associated with mild to moderate rather than intense . Observable signs include swelling of the , which may appear as a blister-like protrusion on the , often accompanied by conjunctival injection (redness) and synergistic swelling. In more severe cases, the swelling can lead to pseudoptosis, where the upper appears to droop due to the mechanical effects of the , and (inability to fully close the eyelids), increasing the risk of corneal exposure. The duration of chemosis manifestations can vary significantly, with acute presentations resolving within hours to days, whereas forms may persist for weeks. Clinical grading systems assess the severity of these based on the extent of swelling and associated features.

Associated Conditions

Chemosis frequently co-occurs with , where the can exacerbate symptoms by disrupting tear film stability and increasing evaporative loss, potentially leading to a vicious cycle of ocular surface irritation. Additionally, the mechanical pressure from swollen may heighten the risk of through friction against the eyelid or exposure due to incomplete closure. Systemic conditions linked to chemosis include autoimmune disorders such as Sjögren's syndrome, which often presents with severe dry eye that can manifest or worsen as conjunctival due to dysfunction. Malignancy-related associations, particularly orbital tumors like choroidal melanoma or metastatic breast carcinoma, can cause chemosis through mass effect, venous obstruction, or inflammation in the orbit. Post-surgical states, especially following or other eyelid procedures, commonly feature chemosis as a result of lymphatic disruption and transient . Epidemiologically, chemosis shows higher incidence in pediatric groups with , such as those with , where allergic inflammation drives conjunctival swelling.

Diagnosis

History and Examination

The clinical assessment of chemosis begins with a detailed patient to identify potential triggers and associated factors. Clinicians inquire about the onset and duration of symptoms, noting whether the swelling appeared acutely (e.g., within hours to days, as in allergic reactions or ) or subacutely (e.g., over weeks, suggesting chronic inflammation). Questions focus on possible exposures, including recent contact with allergens such as , , or pet dander, particularly in patients with a history of or seasonal patterns. Recent infections, such as upper respiratory illnesses or exposure to individuals with conjunctivitis, are explored, along with any history of ocular , including rubbing, surgery, or foreign body contact. Systemic symptoms like fever, rash, pruritus, or respiratory issues are also elicited to contextualize the presentation. The physical examination starts with an external assessment of the eyelids and periorbital area for , , or , followed by evaluation of the for visible swelling. Slit-lamp biomicroscopy is essential to magnify and assess the extent of chemosis, revealing conjunctival that may appear as blister-like protrusions, often graded qualitatively as mild (localized), moderate (extending over the limbus), or severe (ballooning with forniceal involvement). This also identifies associated injection, papillary changes, or follicular reactions. Fluorescein is applied to detect any epithelial defects on the or , which may indicate secondary complications like erosions. An everted is performed to inspect the tarsal and forniceal for hidden involvement, such as giant papillae or in severe cases. Red flags during history and examination warrant urgent evaluation for orbital or deeper involvement. These include acute vision loss, which may signal corneal compromise; proptosis or eyelid lag, suggestive of orbital inflammation or ; and restricted extraocular , indicating possible or neuropathy. The presence of severe , fever, or unilateral proptosis further heightens concern for infectious or compressive etiologies.

Differential Diagnosis

Chemosis, characterized by and ballooning of the at the limbus, must be differentiated from conditions presenting with similar periorbital or conjunctival swelling to ensure accurate . , particularly in children, can mimic chemosis through localized conjunctival redundancy and exposure but lacks the diffuse limbal ballooning typical of chemosis; it often results from laxity or without the blister-like transudation seen in chemosis. Orbital pseudotumor, or idiopathic orbital , may present with chemosis alongside proptosis, pain, and restricted motility due to deeper orbital involvement, distinguishing it from isolated superficial chemosis through systemic inflammatory markers and imaging findings. Allergic lid , involving periorbital swelling from release, can resemble chemosis but is differentiated by predominant eyelid involvement without prominent conjunctival elevation at the limbus and by response to antihistamines. Diagnostic aids play a crucial role in excluding mimics. For suspected infectious causes, conjunctival swab cultures help identify bacterial pathogens in cases of purulent discharge accompanying swelling, guiding differentiation from noninfectious edema. Orbital computed tomography (CT) or magnetic resonance imaging (MRI) is essential for deeper involvement, revealing proptosis, extraocular muscle enlargement, or abscesses in orbital pseudotumor or cellulitis that may simulate chemosis, whereas isolated chemosis shows no such orbital changes. Allergy testing, including skin prick tests or serum immunoglobulin E (IgE) levels, confirms IgE-mediated reactions in allergic differentials, with elevated tear or serum IgE supporting allergic etiology over other causes. Rare mimics include or presenting with cystic conjunctival swellings that resemble chemosis but feature persistent, non-pitting lesions; often shows grape-like vesicles, while amyloid deposits may calcify, confirmed via . In the 2020s, distinguishing chemosis from long COVID ocular effects, such as persistent conjunctival hyperemia or from post-viral inflammation, relies on history of recent infection and resolution patterns, as may involve low-grade inflammation without acute triggers.

Management

Supportive Measures

Supportive measures for chemosis focus on alleviating discomfort and preventing complications through non-invasive, general strategies applicable across etiologies. Cold compresses, applied gently to the closed eyelids for 10-15 minutes several times daily, can reduce and swelling by constricting blood vessels and limiting fluid accumulation in the . or lubricating ointments provide essential moisture to the ocular surface, countering dryness and that may exacerbate the . In cases where incomplete closure occurs, taping the upper to the or brow at night helps protect the from exposure and promotes better fluid drainage. Lifestyle modifications play a key role in minimizing symptom progression. Patients should avoid environmental irritants such as smoke, wind, dust, and allergens, which can worsen conjunctival edema by triggering further inflammation. Elevating the head during sleep, using an extra pillow to maintain a 30-45 degree angle, reduces fluid pooling in the periorbital tissues overnight. Regular is essential to track and detect any worsening, particularly in bilateral chemosis where systemic involvement may be present. Follow-up examinations every 1-2 weeks allow for assessment of symptom persistence and adjustment of care as needed.

Cause-Specific Interventions

For allergic causes of chemosis, treatment targets the underlying reaction in the . Topical antihistamines, such as hydrochloride 0.1% or 0.2% administered twice daily, effectively alleviate symptoms including chemosis by blocking H1 receptors and reducing . Dual-action agents like also stabilize s, preventing further mediator release and providing rapid relief from conjunctival in seasonal or . stabilizers, including cromolyn sodium 4% used four times daily or sodium 2% twice daily, are recommended for prophylactic in mild to moderate cases to inhibit and limit chemosis recurrence. In severe or flares, short courses of oral corticosteroids may be employed under to control intense , though for systemic side effects is essential. Infectious etiologies require etiology-specific antimicrobial therapy to eradicate pathogens and resolve secondary chemosis. For bacterial infections, such as those caused by Staphylococcus or Streptococcus species leading to purulent conjunctivitis, topical antibiotic drops like erythromycin 0.5% ointment applied four times daily for 5-7 days are a first-line option, promoting rapid microbial clearance and reduction in conjunctival swelling. Broader-spectrum agents, such as fluoroquinolone drops (e.g., moxifloxacin 0.5%), may be used if resistance is suspected. For viral causes, particularly herpes simplex virus (HSV)-associated keratoconjunctivitis, topical antivirals like ganciclovir 0.15% gel applied five times daily for 7 days target viral replication and mitigate chemosis, with evidence of faster epithelial healing compared to supportive care alone. Adenoviral conjunctivitis often self-resolves within 1-2 weeks, but supportive antivirals like ganciclovir may shorten shedding duration in severe cases; systemic acyclovir is reserved for immunocompromised patients or neurotrophic keratitis. For postoperative chemosis, commonly following procedures like due to lymphatic disruption, initial management builds on supportive measures with additions such as hypertonic saline drops to draw out fluid and topical corticosteroids to reduce . For persistent cases, options include subconjunctival injections or surgical interventions like conjunctival resection or to restore and resolve refractory . For other causes, interventions address the primary insult to prevent persistent chemosis. In traumatic cases involving conjunctival laceration or from blunt injury, surgical of devitalized tissue under facilitates healing and reduces fluid accumulation, particularly if or foreign bodies are present. For systemic fluid overload, such as in congestive or renal disease, like 20-40 mg orally or intravenously once or twice daily help alleviate generalized including periorbital chemosis by promoting and restoring .

Prognosis

Typical Course

The typical course of chemosis varies based on its underlying , with most cases following an acute pattern of onset and resolution, while others exhibit chronic persistence or recurrent episodes. In acute scenarios, such as those triggered by , symptoms often improve within 1 to 7 days following initiation of with antihistamines, stabilizers, or short-term topical corticosteroids, though mild cases may resolve in hours to days upon allergen avoidance. Infectious causes, including bacterial or , generally require 7 to 14 days for resolution, with bacterial forms responding to a 7- to 10-day course of drops and cases self-limiting over 1 to 2 weeks. Early intervention with targeted therapies, such as anti-inflammatory agents, can shorten these durations by addressing the inflammatory cascade promptly. Chronic patterns are observed in systemic or allergic disorders like untreated thyroid eye disease, where chemosis may persist for months to years during the active inflammatory phase, potentially stabilizing after 18 months but leaving residual orbital changes if unmanaged. In , a recurrent allergic condition, chemosis contributes to a course with seasonal exacerbations tied to environmental triggers like , affecting young males predominantly and persisting beyond in approximately 12% of cases despite treatment. Untreated severe instances across etiologies heighten the risk of progression to secondary issues, underscoring the importance of timely management to alter the disease trajectory.

Complications

Severe or prolonged chemosis can impair eyelid closure, leading to corneal exposure and subsequent exposure keratopathy, a condition where the cornea dries out and becomes vulnerable to damage. This exposure increases the risk of corneal ulceration, particularly in cases where chemosis causes significant lagophthalmos (incomplete eyelid closure). Secondary bacterial superinfection may develop as a complication, progressing to infectious keratitis if the compromised ocular surface allows bacterial invasion. In chronic or severe instances, persistent inflammation from chemosis can contribute to symblepharon, the formation of adhesions between the conjunctiva and cornea or other conjunctival surfaces. Chemosis may serve as an indicator of underlying systemic conditions, including or , especially when accompanied by proptosis, ophthalmoplegia, or vision changes. In such cases, orbital involvement can rarely lead to vision-threatening complications like compression or severe elevation. Recent data highlight an elevated risk of complications from chemosis in aging populations, particularly those with dry eye comorbidities, where reduced tear film stability and delayed epithelial healing exacerbate corneal exposure and ulceration risks.

References

  1. [1]
    Chemosis: MedlinePlus Medical Encyclopedia
    May 10, 2023 · Chemosis is a sign of eye irritation. The outer surface of the eye (conjunctiva) may look like a big blister. It can also look like it has fluid in it.
  2. [2]
    Allergic Conjunctivitis - EyeWiki
    Mar 26, 2025 · Allergic conjunctivitis is an inflammatory response of the conjunctiva to an allergen. It is part of a larger systemic atopic reaction and is usually seasonal.<|control11|><|separator|>
  3. [3]
    Conjunctivitis - StatPearls - NCBI Bookshelf - NIH
    The common symptoms are itching, watering, and chemosis in younger children. This condition is commonly seen in young children playing outdoors in summer or ...
  4. [4]
    Chemosis from Trauma - PMC - NIH
    Chemosis is nonspecific finding and is secondary to direct conjunctival endothelial insult. It can result from allergic reaction, bacterial or viral infection, ...
  5. [5]
    An Unusual Case of Bilateral Hemorrhagic Chemosis in the ... - NIH
    Aug 12, 2020 · Chemosis can be caused by several conditions including infection, trauma, eye surgery, allergic reaction, and certain medications [1,3,4].
  6. [6]
    Persistent Conjunctival Chemosis after Lower Lid Blepharoplasty - NIH
    Apr 3, 2024 · Chemosis is defined as a transudative edema of the bulbar conjunctiva and/or fornix that creates a space between the conjunctiva and Tenon's ...<|control11|><|separator|>
  7. [7]
    Swollen Conjunctiva - American Academy of Ophthalmology
    Jun 19, 2012 · The conjunctiva may swell and accumulate fluid causing a condition known as chemosis. Chemosis has no pain, tenderness, or redness.
  8. [8]
    The comprehensive management of chemosis following ... - PubMed
    Chemosis is a common complication of lower blepharoplasty. Pharmacologic, mechanical, and surgical therapies may be used alone or in combination for the ...
  9. [9]
    Chemosis: What It Is, Possible Causes & Treatment Options
    Jan 29, 2024 · Chemosis (or conjunctival chemosis) is a blister-like swelling of the conjunctiva, the clear membrane that covers the whites of your eyes.
  10. [10]
    chemosis - Definition | OpenMD.com
    Greek cheme = cockleshell + -osis = condition. From a supposed resemblance of the swollen conjunctiva to a cockleshell. Definitions related to chemosis:.
  11. [11]
    Conjunctival Injection: What Is It, Causes, Diagnosis, and More
    Sep 3, 2025 · A subconjunctival hemorrhage can occur if the individual has been straining, like during coughing, sneezing, vomiting, or defecating.
  12. [12]
    Subconjunctival hemorrhage (broken blood vessel in eye)
    A subconjunctival hemorrhage is the bursting of a tiny blood vessel in the protective tissue covering the eye. This clear tissue, called the conjunctiva ...
  13. [13]
    Chemosis | Dr. Brett Kotlus, Cosmetic Oculoplastic Surgeon, NYC
    Chemosis. What is chemosis. Swelling (edema) forms in the conjunctiva, the ... A gelatinous swelling over the white part of the eye. It may occur in an ...
  14. [14]
    Dealing with Conjunctival Chemosis - Cataract Coach
    Oct 15, 2018 · ... conjunctiva and this will spread around the limbus until there is 360° of chemosis. This puffy, inflated conjunctiva will allow fluid to ...
  15. [15]
    Conjunctivitis - EyeWiki
    Sep 30, 2025 · Bacterial conjunctivitis​​ Symptoms include massive exudation, severe chemosis, eyelid edema, marked conjunctival hyperemia, and if left ...Disease Entity · Pathophysiology · Diagnosis · Physical ExaminationMissing: definition | Show results with:definition
  16. [16]
    Blog - Patel Plastic Surgery Salt Lake City and St. George
    Jul 22, 2024 · Chemosis is best graded as mild, moderate and severe. ​Mild Chemosis: there is mild conjunctival elevation with underlying fluid. The ...
  17. [17]
    Chemosis - Vagelos College of Physicians and Surgeons
    Chemosis · Sweeling of bulbar or tarsal conjunctiva. · Usually associated with various ocular conditions: Allergic conjunctivitis; Conjunctival infection ...Missing: etymology | Show results with:etymology<|control11|><|separator|>
  18. [18]
    Histamine-Induced Conjunctivitis and Breakdown of Blood–Tear ...
    Jul 9, 2019 · The mechanism of histamine-induced disruption of the blood–tear barrier is unknown. Increased vascular permeability likely plays a role ...
  19. [19]
    Cytokines in Allergic Conjunctivitis - PubMed Central - NIH
    IL-6 can activate vascular endothelial cells to induce endothelial dysfunction and vascular permeability as well as the recruitment of immune cells and ...
  20. [20]
    Physiology, Edema - StatPearls - NCBI Bookshelf
    May 1, 2023 · Edema is believed to be the outward filtration predominating the arterial end of the capillary, and as hydrostatic pressures fall, fluid reverts ...
  21. [21]
    Ocular Redness – II: Progress in Development of Therapeutics ... - NIH
    Helleboid and colleagues established an association between the degranulation of mast cells to release histamine and increased ... increased vascular permeability ...<|control11|><|separator|>
  22. [22]
    Ophthalmia Neonatorum - StatPearls - NCBI Bookshelf - NIH
    Jul 7, 2025 · Whether chemical, bacterial, or viral in origin, the resulting inflammatory cascade leads to hallmark signs—chemosis, conjunctival injection ...
  23. [23]
    Basic Histology of the Eye and Accessory Structures - EyeWiki
    Conjunctiva. The conjunctiva is a transparent mucous membrane that lines the inner surface of the eyelids (palpebral conjunctiva) and the anterior surface of ...
  24. [24]
    Anatomy, Head and Neck, Eye Conjunctiva - StatPearls - NCBI - NIH
    The conjunctiva of the eye provides protection and lubrication of the eye by the production of mucus and tears. It prevents microbial entrance into the eye ...Introduction · Structure and Function · Blood Supply and Lymphatics · Muscles
  25. [25]
    Assessment of the Watery Eye - StatPearls - NCBI Bookshelf
    In addition, associated conjunctival chemosis disrupts tear flow along the lower eyelid. Due to surgery, trauma, or skin conditions: Any of these may trigger ...
  26. [26]
    Treating Allergies in Contact Lens Wearers
    Apr 1, 2008 · Type I, or immediate hypersensitivity, is the mechanism behind a typical case of allergic conjunctivitis. When an allergen enters the body it ...
  27. [27]
    Allergic Conjunctivitis: Review of Current Types, Treatments, and ...
    May 21, 2024 · The increased levels of histamine cause the dilation of blood vessels, the stimulation of nerve endings, and the activation of mucous-producing ...
  28. [28]
    Allergies and Contact Lens Intolerance: Breaking the Cycle
    Jan 6, 2025 · Patients suffering from GPC may complain of itchy, painful eyes, more with blinking or in the presence of an irritant, such as during contact ...
  29. [29]
    Chemosis Eye Irritation Treatment Beverly Hills | Common Causes
    Angioedema refers to swelling that occurs beneath the skin as opposed to the surface. A form of allergic reaction, angioedema tends to occur around the mouth ...What Is Chemosis? · 2. Allergies · 3. Angioedema
  30. [30]
    Vernal keratoconjunctivitis | Eye - Nature
    Apr 7, 2004 · VKC is a chronic bilateral inflammation of the conjunctiva characterized by hyperaemia, chemosis, photophobia, and filamentous and sticky mucous ...
  31. [31]
    Pathophysiology of Graves' ophthalmopathy - PubMed
    Pathohistological characteristics of Graves' ophthalmopathy (GO) include glycosaminoglycan deposition in the orbit, active inflammatory process, fibrosis of ...
  32. [32]
    Superior limbic keratoconjunctivitis: a comprehensive review
    Superior limbic keratoconjunctivitis (SLK) is characterized by chronic inflammation of the superior limbus and superior bulbar and tarsal conjunctivae.
  33. [33]
    A contemporary look at allergic conjunctivitis
    Jan 21, 2020 · Allergic eye disease is common, affecting approximately 40% of the North American population and increasing in prevalence [1,2,3]. Most patients ...
  34. [34]
    Acute Bacterial Conjunctivitis - Eye Disorders - Merck Manuals
    Bacterial conjunctivitis is usually caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus species, Moraxella catarrhalis or, less commonly, ...
  35. [35]
    Bacterial Conjunctivitis - EyeWiki
    Apr 29, 2025 · Acute bacterial conjunctivitis is primary due to Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae. Other pathogens ...
  36. [36]
    Orbital Cellulitis - EyeWiki
    Oct 19, 2025 · The presence of the following signs is suggestive of orbital involvement: proptosis, chemosis, pain with eye movements, ophthalmoplegia, and ...Disease Entity · General Pathology · Diagnosis · Management
  37. [37]
    Orbital Cellulitis - StatPearls - NCBI Bookshelf
    ... cellulitis does not involve the globe itself. Although orbital cellulitis ... Chemosis (conjunctival swelling) is more commonly present in orbital cellulitis ...
  38. [38]
    Viral Conjunctivitis - StatPearls - NCBI Bookshelf - NIH
    Conjunctivitis causes the eye to appear erythematous secondary to the dilation of blood vessels and is usually accompanied by increased tearing and/or mucoid ...<|control11|><|separator|>
  39. [39]
    Epidemic Keratoconjunctivitis - EyeWiki
    Treatment · In limited studies, antiviral ganciclovir gel has been shown to shorten the duration of EKC and reduce the development of subepithelial infiltrates.
  40. [40]
    Herpes Simplex Ophthalmicus - StatPearls - NCBI Bookshelf - NIH
    Apr 17, 2023 · Herpes simplex ophthalmicus is an eye infection by the herpes simplex type 1 and type 2 viruses. It is ubiquitous and affects all the ages of the population.
  41. [41]
    EyeRounds.org: Adult-Chlamydial-Conjunctivitis-Red-Eyes-Chronic
    Feb 28, 2007 · Chlamydial conjunctivitis is often a unilateral disease but can involve both eyes. Patients complain of pink/red eye, mucous discharge, crusting ...
  42. [42]
    Trachoma - StatPearls - NCBI Bookshelf
    Apr 20, 2024 · Trachoma is a debilitating eye disease caused by the Chlamydia trachomatis bacterium and is one of the leading causes of blindness worldwide.
  43. [43]
    Orbital Fungal Infection: Complex Case Exhibits Keys to Diagnosis ...
    Dec 10, 2021 · Fungal infections are primarily found in immunocompromised patients. Neoplastic etiologies include meningeal infiltration of leukemia or ...
  44. [44]
    Fungal Keratitis - StatPearls - NCBI Bookshelf - NIH
    Feb 12, 2024 · Fungal keratitis is a serious condition that demands prompt and effective intervention. Neglecting proper treatment can result in corneal destruction and ...
  45. [45]
    Ophthalmic Manifestations of Coronavirus (COVID-19) - NCBI - NIH
    May 6, 2024 · In advanced cases, patients may present with chemosis (see Image. Chemosis) or follicular conjunctivitis (see Image. Follicular Conjunctivitis).
  46. [46]
    Characteristics of Ocular Findings of Patients With Coronavirus ...
    A total of 12 of 38 patients (31.6%; 95% CI, 17.5-48.7) had ocular manifestations consistent with conjunctivitis, including conjunctival hyperemia, chemosis, ...
  47. [47]
    Dry eye symptoms and chemosis appear common following ...
    Jan 18, 2013 · Intraoperative canthopexy significantly increased the risk for developing chemosis (occurring in 45 percent with canthopexy vs. 25.5 percent ...
  48. [48]
    Strabismus Surgery Complications - EyeWiki
    May 12, 2025 · Strabismus surgery is very safe and effective, but complications can occur and need to be diagnosed and treated early to optimize post-operative outcome.
  49. [49]
    Bacterial Keratitis - StatPearls - NCBI Bookshelf - NIH
    The various signs of bacterial keratitis are lid edema, blepharospasm, matting of eyelashes, purulent discharge, conjunctival chemosis, circumcorneal congestion ...
  50. [50]
    Diagnostic Procedures in Patients With Superior Vena Cava ...
    Understandably, the swollen plethoric face, the conjunctival edema of chemosis, and the distended neck veins and collaterals that indicate superior vena.
  51. [51]
    Severe chemosis in a patient with nephrotic syndrome
    Jul 26, 2008 · In our patient we think that chemosis was the consequence of fluid retention due to hypoproteinemia. We would like to speculate that it ...Missing: failure overload
  52. [52]
    Characteristics and associated risk factors of exposure keratopathy ...
    Apr 11, 2025 · Of 156 ventilated patients included in this study, 42.3% had exposure keratopathy, 13.5% had lagophthalmos, and 26.9% of patients had chemosis.
  53. [53]
    Prevalence and risk factors of exposure keratopathy among critically ...
    Dec 14, 2023 · Risk factors associated with EK in critically ill patients included lagophthalmos, chemosis, eye blinks <5 times per minute, mechanical ventilation, sedation, ...
  54. [54]
    Chemosis: Causes, Symptoms and Treatment - All About Vision
    Jan 26, 2021 · Allergies – Even if you don't develop angioedema, seasonal or other allergies can cause chemosis. An eye infection – An eye infection caused by ...Symptoms Of Chemosis · Chemosis Causes · Chemosis Eye Treatment
  55. [55]
    What causes swelling on the white part of your eye? - Acuvue
    Aug 25, 2025 · Chemosis (conjunctival edema) is a blister-like swelling of the clear tissue that covers the white part of your eye.
  56. [56]
    Conjunctival Chemosis: What Causes It and How It Is Treated
    May 30, 2023 · Chemosis Caused by Allergies. When allergies make the eyes red and swollen, the resulting condition is sometimes called allergic conjunctivitis.
  57. [57]
    Chemosis - UF Health
    Chemosis is swelling of the eye surface membranes because of accumulation of fluid. This symptom is often related to an allergic response.
  58. [58]
    Cosmetic blepharoplasty and dry eye disease - PubMed Central - NIH
    Chemosis is closely related to dry eye disease, because severe and persistent chemosis may destroy the goblet cells, thereby resulting in unstable tear film ...<|separator|>
  59. [59]
    When Dry Eye Disease is a Secondary Condition
    Oct 15, 2017 · Conditions that may cause conjunctival chemosis include long-standing allergic conjunctivitis, dry eye, trauma or inflammatory conditions such ...
  60. [60]
    Sjögren's Syndrome: More Than Just Dry Eye - PMC - PubMed Central
    The purpose of this article is to illustrate that in addition to dry eye, SS can cause serious, vision-threatening extraglandular ocular manifestations.
  61. [61]
    Orbital cellulitis and massive chemosis as first sign of a cilio ...
    The massive chemosis presented in our case was surely the most striking manifestation of the tumor. Unlike retinoblastoma, which is known to manifest with ...
  62. [62]
    “Ocular Surface Disorders in Children”: A Comprehensive Review of ...
    OSD affects a significant portion of the population, from 5% to 50%, and the prevalence increases with age. ... VKC is more frequent in tropical and dry climates ...<|control11|><|separator|>
  63. [63]
    Atopic dermatitis associated with tropical endemic limbo-conjunctivitis
    Apr 5, 2023 · Atopic dermatitis (AD) is on the increase worldwide. In Africa, 40% of cases are associated with tropical endemic limbo-conjunctivitis (TELC).
  64. [64]
    Conjunctivitis - EyeWiki
    Sep 30, 2025 · Bacterial conjunctivitis​​ Symptoms include massive exudation, severe chemosis, eyelid edema, marked conjunctival hyperemia, and if left ...Disease Entity · Pathophysiology · Diagnosis · Physical Examination
  65. [65]
    Chemosis Information | Mount Sinai - New York
    Chemosis is swelling of the eye surface membranes because of accumulation of fluid. This symptom is often related to an allergic response.
  66. [66]
    Surgical Treatment of Chemotic Conjunctival Prolapse ... - PubMed
    The fine suspensory attachments of the conjunctival fornix may be disrupted by the hydraulic dissection of marked chemosis, leading to prolapse of the ...
  67. [67]
    Approach to Generalized Eyelid Edema - EyeWiki
    Sep 17, 2025 · Clinically, it presents as a rapidly progressive eyelid oedema and erythema with or without conjunctival congestion and chemosis, pain, ...
  68. [68]
    the importance of good-quality conjunctival swabs - PMC - NIH
    It highlights the importance of good-quality conjunctival swabs. Swabs need to sweep relatively deeply into the inferior conjunctival fornix, which can be ...Missing: aids | Show results with:aids
  69. [69]
    Orbital inflammatory disease: Pictorial review and differential ...
    The differential diagnosis for inflammatory orbital cellulitis includes infection, CCF, cavernous sinus thrombosis, and Wegener's granulomatosis. Careful ...
  70. [70]
    Allergic Conjunctivitis - StatPearls - NCBI Bookshelf - NIH
    Jan 26, 2024 · Macropapillae, smaller than 1 mm in size, appear as flat-topped lesions with a polygonal (cobblestone-like) appearance. These macrophiles ...
  71. [71]
    Conjunctival Lymphangiectasia - EyeWiki
    Jul 22, 2025 · In the diffuse form, there is swelling of the conjunctiva (chemosis), and the lymphatic vessels are spread out over a wide area. ... amyloidosis ...Missing: mimic | Show results with:mimic
  72. [72]
    Conservative Management in Congenital Bilateral Upper Eyelid ...
    Conservative management includes applying moist dressings, eyelid taping, and pressure patching along with topical antibiotic and lubricants. Additionally, ...
  73. [73]
    Chemosis After Blepharoplasty: Causes, Treatment, and Healing ...
    May 28, 2025 · Chemosis. Gelatinous conjunctival swelling, may protrude over eyelid ; Conjunctivitis. Redness, discharge, often infectious or allergic in origin.
  74. [74]
    What is the initial management for a patient presenting with chemosis?
    Oct 13, 2025 · Follow-up Recommendations. Follow-up within 1-2 weeks is recommended if symptoms persist 2; For patients treated with topical corticosteroids ...
  75. [75]
    Treatment of allergic conjunctivitis with olopatadine hydrochloride ...
    Olopatadine hydrochloride ophthalmic solution has an excellent, strong, and safe anti-allergic effect in vitro and it provides superior clinical effectiveness ...
  76. [76]
    Topical antihistamines and mast cell stabilisers for treating seasonal ...
    Topical antihistamines and mast cell stabilisers reduce symptoms and signs of seasonal allergic conjunctivitis when compared with placebo in the short term.
  77. [77]
    ICON: diagnosis and management of allergic conjunctivitis
    Nov 20, 2019 · Immunoassays for IgE determination represent secondary allergy test for diagnosis of sensitization in patients with ocular allergy. • ...
  78. [78]
    Ocular Allergic Surface Disease Symptoms Associated with Atopic ...
    We report the use of dupilumab in a patient with AD, asthma and atopic keratoconjunctivitis (AKC) resulting in improvement in all three conditions.
  79. [79]
    Erythromycin - StatPearls - NCBI Bookshelf - NIH
    Erythromycin is a macrolide antibiotic initially discovered in 1952. It is useful for treating various infections and also has an indication for a non- ...
  80. [80]
    Viral Conjunctivitis (Pink Eye) Treatment & Management
    Mar 1, 2024 · Patients with conjunctivitis caused by HSV usually are treated with topical antiviral agents, including ganciclovir gel, idoxuridine solution ...
  81. [81]
    Ganciclovir ophthalmic gel, 0.15%: a valuable tool for treating ocular ...
    Ganciclovir ophthalmic gel, 0.15% is an effective and well tolerated antiviral treatment for superficial acute herpetic keratitis.
  82. [82]
    Diuretic Therapy for Patients With Heart Failure - JACC
    Mar 9, 2020 · In patients with heart failure, the dose-response curve is shifted downward and to the right. Note that the x-axis for diuretic dose is on the ...
  83. [83]
    Exposure Keratopathy - EyeWiki
    Exposure Keratopathy. From EyeWiki. Jump to:navigation, search. All content on ... Assess for conjunctival injection or chemosis. Symptoms. Patients may ...
  84. [84]
    Ophthalmology in Critical Care | Annals of the American Thoracic ...
    Dec 3, 2018 · Another significant risk factor for developing exposure keratopathy is chemosis, or conjunctival edema, because it inhibits complete eyelid ...<|control11|><|separator|>
  85. [85]
    The etiologic and pathogenic spectrum of exposure keratopathy
    ... corneal ulceration, stromal melting, and finally, superficial ... chemosis, lower Glasgow Coma Scale (GCS), and higher Acute Physiology and Chronic ...
  86. [86]
    [PDF] CHRONIC CORNEAL DISEASES - CABI Digital Library
    chemosis. Symblepharon is the adhesion of conjunctiva to itself or to the cornea. A corneal ulcer does not have to be present for symblepharon to occur.<|control11|><|separator|>
  87. [87]
    Malignant Orbital Tumors - StatPearls - NCBI Bookshelf - NIH
    Apr 21, 2024 · Patients presenting with decreased or double vision, ophthalmoplegia, chemosis, and proptosis should raise concerns for orbital malignancy.
  88. [88]
    Orbital Vasculitis - EyeWiki
    Jul 10, 2025 · Due to the rich vascular supply in the orbit, orbital vasculitis often presents with early symptoms, making it a critical sign of underlying, ...Disease Entity · Pathophysiology · Diagnosis · Etiological Presentations
  89. [89]
    Infectious Keratitis in Patients Over 65: A Review on Treatment and ...
    Jul 31, 2024 · This review comprehensively assesses risk factors, clinical characteristics, and management strategies for bacterial, viral, fungal, and acanthamoeba keratitis ...